找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Antiviral Strategies; Hans-Georg Kr?usslich,Ralf Bartenschlager Book 2009 Springer-Verlag Berlin Heidelberg 2009 Antiviral Drug.DNA.Drug R

[復(fù)制鏈接]
樓主: eternal
31#
發(fā)表于 2025-3-26 21:35:28 | 只看該作者
32#
發(fā)表于 2025-3-27 01:28:54 | 只看該作者
33#
發(fā)表于 2025-3-27 05:47:12 | 只看該作者
https://doi.org/10.1007/11545156 infection and can also be used to treat certain forms of chronic hepatitis B virus infections. IFNs have also been used in other viral infections, although with less success. The antiviral mechanisms of IFNs are reviewed in this chapter as well as the utility of IFNs in the treatment of persistent viral infections.
34#
發(fā)表于 2025-3-27 12:41:50 | 只看該作者
35#
發(fā)表于 2025-3-27 17:15:16 | 只看該作者
36#
發(fā)表于 2025-3-27 18:48:14 | 只看該作者
37#
發(fā)表于 2025-3-27 23:23:43 | 只看該作者
Lecture Notes in Computer Sciencee cycles and, in the context of HIV treatment, contributes to the growing armamentarium of antivirals which, in multidrug combinations, can effectively inhibit viral replication and prevent disease progression.
38#
發(fā)表于 2025-3-28 02:38:13 | 只看該作者
39#
發(fā)表于 2025-3-28 08:59:27 | 只看該作者
Jeremy Rose,Jesper Holgersson,Eva S?derstr?mpidly and will provide further opportunities to explore the efficacy of combination antiviral therapy. While sufficient suppression of HIV RNA and HBV DNA can only be achieved by long-term administration of potent antiviral drugs, HCV RNA may be completely eradicated from the infected individual after a limited duration of treatment.
40#
發(fā)表于 2025-3-28 13:52:13 | 只看該作者
Approaches for the Development of Antiviral Compounds: The Case of Hepatitis C Virus,in Phases 1, 2, and 3, leading to the goal of approved drugs that benefit the infected individual. This review uses hepatitis C virus (HCV), for which we still do not have an ideal therapeutic modality, as an example of the multidisciplinary efforts needed to discover new antiviral drugs for the benefit of humanity.
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-25 00:17
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
罗城| 炎陵县| 宽城| 南宫市| 辛集市| 雷州市| 奉贤区| 中山市| 洛南县| 象州县| 定陶县| 微山县| 宁波市| 永吉县| 正镶白旗| 鄱阳县| 南康市| 镇赉县| 垣曲县| 永年县| 区。| 中牟县| 江达县| 含山县| 宣武区| 永年县| 赤水市| 新野县| 织金县| 临沭县| 贵南县| 吉安县| 新化县| 科技| 信宜市| 雷波县| 蒲城县| 平乡县| 张家口市| 长岛县| 桦甸市|